Varicose Veins: Sclerotherapy, Surgery, or Laser? How to Choose a Treatment Method

Deciding how to treat varicose veins used to come down, in practice, to one option — classic vein removal (stripping). Today a patient chooses between sclerotherapy, laser or radiofrequency endovenous ablation, and traditional surgery — methods that differ in invasiveness, recovery time, and which type of varicose veins they suit. None of them, though, guarantees that the veins won't come back.

AKdr Anna KowalczykOctober 17, 202613 min read

Table of contents

TL;DR — key takeaways

→From stripping to endovenous ablation — a shift over the past two decades
→Three main options — how they work and how they differ
→What the Cochrane systematic review shows — ablation versus surgery
→Myth vs. fact: does a modern method mean no recurrence
→When sclerotherapy is enough, and when ablation or surgery is needed
→What none of these methods treats
→Limitations of this data
→Summary
→Our editorial recommendation

From stripping to endovenous ablation — a shift over the past two decades

For most of the 20th century, the standard treatment for varicose veins in the large superficial veins was an operation called stripping (venectomy) — the surgical removal of the entire failing vein, usually the great saphenous vein, by inserting a probe and pulling the vessel out through small skin incisions. The procedure required general or spinal anesthesia, a hospital stay, and several weeks of recovery with limited activity.

Over the past two decades, vascular surgery practice has shifted noticeably toward endovenous methods — laser ablation (endovenous laser ablation, EVLA) and radiofrequency ablation (RFA) — performed under local anesthesia, on an outpatient basis, without the need for hospitalization. This shift isn't purely a matter of fashion or marketing: it's backed by a solid body of randomized trials and systematic reviews comparing the newer methods with classic surgery, which we cover later in this article.

This article concerns choosing a procedural treatment method for varicose veins — not symptomatic flavonoid supplementation, which helps relieve symptoms of chronic venous insufficiency but doesn't remove the varicose veins themselves or replace procedural treatment for larger, visible veins. We cover that separate topic, based on a different study, in our article on flavonoids and chronic venous insufficiency.

Three main options — how they work and how they differ

Sclerotherapy involves injecting a sclerosing agent into the vein (most often polidocanol foam in newer protocols, known as ultrasound-guided foam sclerotherapy, UGFS), which damages the vessel's inner lining, causing it to collapse and fibrose. The procedure is done on an outpatient basis, with no anesthesia beyond a local one at the injection site, and works best for smaller-caliber varicose veins, reticular veins, and spider veins, as well as — in the ultrasound-guided version — some larger trunk veins.

Endovenous ablation (laser EVLA or radiofrequency RFA) involves inserting a catheter that emits thermal energy into the lumen of the failing vein, which damages the vessel wall from the inside, leading to its closure (occlusion) and fibrous overgrowth. The procedure is performed under local (tumescent) anesthesia, under ultrasound guidance, without surgical incisions other than at the catheter entry point — the patient usually returns to normal activity within 1–2 days.

Classic surgery (high ligation and stripping) remains the method with the longest clinical history and is still used, especially for very large, heavily tortuous varicose veins, recurrences after previous endovenous treatment, or when vein anatomy prevents safe insertion of an ablation catheter. It requires surgical incisions, usually general or regional anesthesia, and a longer recovery period than endovenous methods.

What the Cochrane systematic review shows — ablation versus surgery

Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus open surgery for great saphenous vein varices

Strong evidence

Nesbitt C, Bedenis R, Bhattacharya V, Stansby G · Cochrane Database of Systematic Reviews · 2014

A Cochrane systematic review included 13 randomized trials with a combined total of 3,081 patients, comparing ultrasound-guided foam sclerotherapy (UGFS), laser ablation (EVLA), and radiofrequency ablation (RFA) with classic surgery (high ligation and stripping) of the great saphenous vein. No clinically meaningful difference was found in clinically assessed recurrence rates between UGFS, EVLA, or RFA and surgery. Laser ablation was associated with a lower rate of neovascularization (regrowth of new, abnormal vessels at the treatment site) and a lower rate of technical failure than surgery. Quality of life improved similarly across all compared groups. The authors concluded that endovenous methods are "at least as effective as surgery," while noting that inconsistent outcome reporting across the trials limits the strength of this conclusion.

View study

Parameter	Endovenous ablation (EVLA/RFA)	Surgery (stripping)
Anesthesia	Local (tumescent)	General or regional
Setting	Outpatient	Usually requires an operating room
Return to activity	Usually 1–2 days	Usually 1–2 weeks or longer
Clinically meaningful recurrence	Comparable to surgery	Comparable to ablation
Neovascularization (EVLA)	Lower than surgery	Higher than EVLA

Endovenous ablation vs. classic surgery — key differences

The most important conclusion from this review isn't that endovenous methods are "better" in terms of long-term effectiveness — on recurrence, they simply perform comparably to surgery. The advantage of endovenous methods lies elsewhere: in considerably lower invasiveness, shorter recovery time, and the ability to perform the procedure on an outpatient basis without general anesthesia. It's precisely this combination of comparable effectiveness with lower invasiveness that explains why endovenous methods have largely replaced classic surgery as the first choice in many vascular surgery centers.

Myth vs. fact: does a modern method mean no recurrence

Myth

Modern laser or radiofrequency ablation is such advanced technology that after this procedure, varicose veins will never come back, unlike with "old-fashioned" surgery.

Fact

The Cochrane review found no meaningful difference in clinically significant recurrence rates between endovenous ablation and surgery — both methods carry a comparable risk of recurrence over long-term follow-up. Recurrence of varicose veins after any treatment method is a common, well-documented phenomenon in the vascular literature, resulting from the progression of venous disease in other, previously untreated sections of the venous system, not from any "imperfection" of a given procedural technology. The advantage of newer methods lies in invasiveness and recovery time, not in a guarantee of permanent cure without the possibility of recurrence.

This distinction has practical importance: the decision about which treatment method to choose should primarily take into account a patient's tolerance for invasiveness, available recovery time, and the anatomy of the specific varicose veins — not a belief that a more expensive or newer technology eliminates the risk of recurrence, which, according to current evidence, no available method eliminates.

When sclerotherapy is enough, and when ablation or surgery is needed

How the treatment method is chosen in clinical practice

Spider veins and smaller-caliber reticular veins — sclerotherapy (often with a classic liquid sclerosing agent injection) is usually a sufficient first option
Larger trunk veins (e.g. the great saphenous vein) with documented valvular insufficiency on Doppler ultrasound — endovenous ablation (laser or radiofrequency) is now the standard first-choice method in many centers
Ultrasound-guided foam sclerotherapy (UGFS) is also sometimes used for larger veins, especially when anatomy makes catheter insertion difficult or when a patient isn't a candidate for a thermal procedure
Very large, heavily tortuous varicose veins, recurrences after previous endovenous treatment, or unusual venous anatomy — classic surgery remains a real, sometimes preferred option in these specific situations
The final choice of method should always rest with a phlebologist or vascular surgeon after a Doppler ultrasound evaluation of the leg veins, taking into account the location, caliber, and degree of valvular insufficiency of the specific vessels

Check your profile

Not sure which supplements actually make sense for you?

Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.

Takes about 2 minutesBased on scientific evidence

Find supplements for me

Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.

What none of these methods treats

Procedural treatment vs. symptomatic supplementation

Sclerotherapy, ablation, and surgery remove or close a specific, failing vein — they don't treat the general predisposition to venous insufficiency, which in some patients leads over time to new varicose veins forming in other sections of the venous system. Supplementing with flavonoids (e.g. MPFF/diosmin), described in our article on chronic venous insufficiency, can relieve symptoms such as leg heaviness or swelling, but doesn't replace any of the procedural methods covered in this article when visible varicose veins or valvular insufficiency require procedural treatment.

General supportive measures regardless of the chosen treatment method

Compression stockings after the procedure, as recommended by the operator — support healing and reduce the risk of post-procedure complications
Avoiding prolonged, uninterrupted standing or sitting, regardless of the treatment method used
Maintaining a healthy body weight, since excess weight increases the load on the leg venous system
Regular phlebology follow-up after the procedure, allowing early detection of any recurrence or new varicose veins forming in other sections

Limitations of this data

What the Cochrane review doesn't settle

The Nesbitt et al. review itself notes a limitation arising from inconsistent outcome reporting across the included trials, which makes it difficult to precisely compare long-term (beyond 5 years) recurrence rates between methods. None of the trials were blinded with respect to the patient or operator — in practice it's hard to blind the fact of whether someone had surgery or an outpatient procedure, which is an unavoidable methodological limitation of this field of surgery, not a flaw of a specific trial. The review focused mainly on the great saphenous vein — its conclusions shouldn't automatically be transferred to varicose veins of the short saphenous vein or anatomically unusual varicose veins, for which separate, usually smaller sets of evidence exist. The choice of a specific method for a specific patient depends on many individual factors (anatomy, coexisting conditions, patient preference) that aren't captured in a meta-analysis's averaged results.

Summary

Question	Short answer
Is endovenous ablation more effective than surgery?	Comparable effectiveness in terms of recurrence — the advantage lies in lower invasiveness and shorter recovery
Which varicose veins does sclerotherapy suit best?	Best for spider veins and smaller-caliber veins; the ultrasound-guided version is also sometimes used for larger veins
Can varicose veins come back after treatment?	Yes — recurrence is possible after every method, well documented in the literature
When is classic surgery indicated?	For very large, tortuous varicose veins, recurrences after ablation, or unusual venous anatomy
Does flavonoid supplementation replace procedural treatment?	No — it relieves symptoms, but doesn't remove varicose veins or repair failing valves

Sclerotherapy, ablation, and surgery for varicose veins at a glance

Our editorial recommendation

The shift from classic surgery to endovenous methods as the first choice for treating great saphenous vein varicose veins is one of the better-documented examples of a clinical practice change grounded in solid evidence from randomized trials, rather than purely market preference or newer-technology marketing. At the same time, an honest presentation of this data requires acknowledging that neither available method — not the newest laser ablation, nor classic surgery — guarantees a permanently recurrence-free outcome. The choice of method is best made with a phlebologist, based on the specific venous anatomy, the invasiveness acceptable to the patient, and the available recovery time, rather than purely on which technology sounds most modern.

The question worth asking before a procedure isn't "which method is newest," but "which method best fits my venous anatomy and my lifestyle during recovery" — the answer to that second question varies between patients far more than the differences in effectiveness between the methods themselves.

Dr. Anna Kowalczyk, VitMode editorial team

Frequently asked questions

The procedure involves mild discomfort at the moment of injection, comparable to a standard blood draw, not significant pain. General anesthesia isn't required.

In most cases, a return to normal activity, including office work, follows within 1–2 days, though recommendations about intense physical activity and wearing compression stockings may extend over several weeks, according to the individual operator's instructions.

Yes, though less often than two decades ago — it remains a real option for very large, heavily tortuous varicose veins, recurrences after previous endovenous treatment, or when vein anatomy doesn't allow safe insertion of an ablation catheter.

Reimbursement rules differ between countries and healthcare systems and depend on the medical indication (symptomatic venous insufficiency) as opposed to purely cosmetic indications. Details should always be verified with the specific provider or payer before the procedure.

Yes — procedural treatment removes or closes a specific, failing vein, but doesn't treat the general predisposition to venous insufficiency. In some patients, varicose veins eventually develop in other sections of the venous system, requiring regular phlebology follow-up after the procedure.

Supplementation (e.g. with flavonoids) can relieve symptoms such as leg heaviness or swelling, but doesn't remove visible varicose veins or repair failing venous valves. With visible, larger varicose veins, a phlebology evaluation and, usually, one of the procedural methods described in this article is indicated.

Endovenous methods (laser or radiofrequency ablation and sclerotherapy) generally involve a shorter return-to-work time than classic surgery, since they're performed under local anesthesia, on an outpatient basis, without surgical incisions requiring longer healing.

Sources

Nesbitt et al. 2014 — Cochrane Database of Systematic Reviews

dr Anna Kowalczyk

PhD in Molecular Biology (University of Warsaw), 8 years researching cellular aging

Anna studied molecular biology at the University of Warsaw, then spent eight years after her PhD in a lab researching the mechanisms of cellular aging and autophagy. She stumbled into science journalism almost by accident — frustrated by how easily her field's findings get oversimplified in the media, she started a blog explaining the biology of aging in plain language. That blog became the seed of VitMode. Today Anna oversees the entire editorial process, holding every piece to the same rigor her old lab demanded: primary sources, methodology checks, and honesty about the limits of the evidence. Outside work, she's a dedicated boulderer.

Flavonoids (Diosmin) and Chronic Venous Insufficiency — What Does the Meta-Analysis Show?

That feeling of heavy, swollen legs by the end of the day, nighttime calf cramps, sometimes visible varicose veins — chronic venous insufficiency affects a huge share of the adult population, especially people who stand or sit for a living. A large meta-analysis of 7 randomized trials with nearly 1,700 patients looked at how these symptoms respond to a micronized purified flavonoid fraction (MPFF, diosmin) — and found one of the lowest NNTs you'll ever see in supplement research.

11 min

August 26, 2026

Lekarz notujący szczegóły podczas konsultacji pacjenta w gabinecie

TRT or Lifestyle Change? What Actually Raises Testosterone Before You Consider Therapy

Before considering testosterone replacement therapy, it's worth checking how much sleep, training, and fat loss can realistically achieve — and when these interventions genuinely aren't enough.

7 min

July 29, 2026

Bogaty wybór świeżych składników na stole — różnorodność zdrowych opcji żywieniowych

Keto, DASH, or Mediterranean? Which Approach Has the Strongest Evidence for Weight Loss

We compare three popular eating patterns based on real scientific evidence — not social media popularity — to help you choose the approach that fits your goal.

8 min

July 31, 2026

Rzędy probówek z próbkami krwi w stojaku laboratoryjnym

5 Biomarkers Worth Knowing Before 40 — Signals Before Symptoms Appear

A standard "once-a-year blood count" often misses early signs of metabolic and hormonal issues. Here are five markers worth asking your doctor about, before anything starts to hurt.